Treatment with IL-4 and -13 stimulates MUC5AC and MUC5B secretion in patients with CRSwNP via IL-4α, which is also highly expressed in patients with IL-5(+) CRSwNP [84]. Here, MUC5B is linked to chronic rhinosinusitis with nasal polyps.